DWTX

NASDAQ 已收盘

Dogwood Therapeutics

1.04 USD
▼-0.03-2.36%
盘后 1.29 +24.64%
2026-11-20
市值
$39.57M
市盈率
—
EPS
-0.86
股息率
—
52 周区间
0.90 – 7.04
成交量
646.48K
Beta
2.11
目标价
14.00
52W 低 0.9052W 高 7.04
价格走势

公司简介

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended t...